Olpinat (Olanzapine)

Olanzapine, the active ingredient in Olpinat, is an atypical antipsychotic presented as a 10 mg tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents. GNH USA supplies Olpinat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olpinat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olpinat is an atypical antipsychotic that acts on dopamine and serotonin pathways to manage serious mental health conditions.

- Schizophrenia: helps reduce positive and negative symptoms and improves overall functioning. - Bipolar I disorder (manic episodes): assists in controlling mood swings and preventing relapse. - Schizoaffective disorder: alleviates psychotic symptoms and stabilises mood. - Psychotic depression: augments antidepressant therapy by reducing psychotic features. - Acute agitation: provides rapid calming effects in emergency settings.

Olpinat may cause a range of adverse reactions, varying from mild to potentially serious.

Common Side Effects: - Weight gain - Sedation - Dry mouth - Constipation - Elevated triglycerides - Dizziness

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hyperglycaemia - Agranulocytosis - Myocardial infarction - Seizures

When prescribing Olpinat, clinicians should consider several safety aspects.

- Monitor blood glucose: patients with diabetes or metabolic risk factors need regular testing. - Assess lipid profile: periodic lipid monitoring is advised. - Watch for extrapyramidal symptoms: observe for signs of movement disorders. - Evaluate cardiac health: baseline ECG may be warranted for patients with cardiac history. - Review hepatic function: dose adjustments may be required in liver impairment. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Olpinat can interact with a variety of medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase olanzapine levels. - CNS depressants (e.g., benzodiazepines) combined with   

Moderate   g   t  ":[""], "metatitle": "Olpinat 10mg Tablet " }